Cargando…

S100A1: A Multifaceted Therapeutic Target in Cardiovascular Disease

Cardiovascular disease is the leading cause of death worldwide, showing a dramatically growing prevalence. It is still associated with a poor clinical prognosis, indicating insufficient long-term treatment success of currently available therapeutic strategies. Investigations of the pathomechanisms u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rohde, David, Ritterhoff, Julia, Voelkers, Mirko, Katus, Hugo A., Parker, Thomas G., Most, Patrick
Formato:	Texto
Lenguaje:	English
Publicado:	Springer US 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933808/ https://www.ncbi.nlm.nih.gov/pubmed/20645037 http://dx.doi.org/10.1007/s12265-010-9211-9

Ejemplares similares

S100A1 is released from ischemic cardiomyocytes and signals myocardial damage via Toll-like receptor 4
por: Rohde, David, et al.
Publicado: (2014)

Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
por: Droste, Annette S, et al.
Publicado: (2009)

S100A1: A Regulator of Striated Muscle Sarcoplasmic Reticulum Ca(2+) Handling, Sarcomeric, and Mitochondrial Function
por: Völkers, Mirko, et al.
Publicado: (2010)

Chemokine receptors: multifaceted therapeutic targets
por: Proudfoot, Amanda E. I.
Publicado: (2002)

Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products
por: Ehlermann, Philipp, et al.
Publicado: (2006)

Glyceraldehyde-3-phosphate Dehydrogenase Is a Multifaceted Therapeutic Target
por: Lazarev, Vladimir F., et al.
Publicado: (2020)

Natriuretic Peptides in the Cardiovascular System: Multifaceted Roles in Physiology, Pathology and Therapeutics
por: Rubattu, Speranza, et al.
Publicado: (2019)

The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention
por: González, María Eugenia
Publicado: (2017)

Vimentin as a Multifaceted Player and Potential Therapeutic Target in Viral Infections
por: Ramos, Irene, et al.
Publicado: (2020)

Eplerenone: The Multifaceted Drug in Cardiovascular Pharmacology
por: Pradhan, Akshyaya, et al.
Publicado: (2020)

The S100B Protein: A Multifaceted Pathogenic Factor More Than a Biomarker
por: Michetti, Fabrizio, et al.
Publicado: (2023)

High-sensitive Troponin T increase after exercise in patients with pulmonary arterial hypertension
por: Völkers, Mirko, et al.
Publicado: (2013)

The multifaceted role of lysine acetylation in cancer: prognostic biomarker and therapeutic target
por: Di Martile, Marta, et al.
Publicado: (2016)

TLR9 and COVID-19: A Multidisciplinary Theory of a Multifaceted Therapeutic Target
por: Bezemer, Gillina F. G., et al.
Publicado: (2021)

Multifaceted role of ferroptosis in cardiovascular disease: Ferroptosis in cardiovascular disease
por: Li, Chengyi, et al.
Publicado: (2023)

MicroRNA-138 Regulates Hypoxia-Induced Endothelial Cell Dysfunction By Targeting S100A1
por: Sen, Anagha, et al.
Publicado: (2013)

Multifaceted prospects of nanocomposites for cardiovascular grafts and stents
por: Vellayappan, Muthu Vignesh, et al.
Publicado: (2015)

The Multifaceted Functions of CXCL10 in Cardiovascular Disease
por: van den Borne, Pleunie, et al.
Publicado: (2014)

USP4 function and multifaceted roles in cancer: a possible and potential therapeutic target
por: Wang, Yizhi, et al.
Publicado: (2020)

Correction: MicroRNA-138 Regulates Hypoxia-Induced Endothelial Cell Dysfunction By Targeting S100A1
por: Sen, Anagha, et al.
Publicado: (2013)

Correction: MicroRNA-138 Regulates Hypoxia-Induced Endothelial Cell Dysfunction By Targeting S100A1
por: Sen, Anagha, et al.
Publicado: (2014)

Intracellular and Extracellular Effects of S100B in the Cardiovascular Response to Disease
por: Tsoporis, James N., et al.
Publicado: (2010)

The S100 Protein Family as Players and Therapeutic Targets in Pulmonary Diseases
por: Sattar, Zeeshan, et al.
Publicado: (2021)

Gp-100 as a Novel Therapeutic Target in Uveal Melanoma
por: Martinez-Perez, Daniel, et al.
Publicado: (2021)

Serratiopeptidase: An integrated View of Multifaceted Therapeutic Enzyme
por: Nair, Sreelakshmi R., et al.
Publicado: (2022)

Celebrating Versatility: Febuxostat’s Multifaceted Therapeutic Application
por: Kraev, Krasimir Iliev, et al.
Publicado: (2023)

Deep Characterization of Circular RNAs from Human Cardiovascular Cell Models and Cardiac Tissue
por: Jakobi, Tobias, et al.
Publicado: (2020)

The Multifaceted Roles of Adipose Tissue—Therapeutic Targets for Diabetes and Beyond: The 2015 Banting Lecture
por: Scherer, Philipp E.
Publicado: (2016)

Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives
por: Behl, Tapan, et al.
Publicado: (2020)

The Multifaceted Uses and Therapeutic Advantages of Nanoparticles for Atherosclerosis Research
por: DiStasio, Nicholas, et al.
Publicado: (2018)

The Multifaceted Therapeutic Mechanisms of Curcumin in Osteosarcoma: State-of-the-Art
por: Zahedipour, Fatemeh, et al.
Publicado: (2021)

The Multifaceted MEP Pathway: Towards New Therapeutic Perspectives
por: Allamand, Alizée, et al.
Publicado: (2023)

The Emerging, Multifaceted Role of WTAP in Cancer and Cancer Therapeutics
por: Ju, Guomin, et al.
Publicado: (2023)

Multifaceted Sexual Dysfunction in Dialyzing Men and Women: Pathophysiology, Diagnostics, and Therapeutics
por: Chou, Jadzia, et al.
Publicado: (2021)

The multifaceted role of pirfenidone and its novel targets
por: Macías-Barragán, José, et al.
Publicado: (2010)

Targeting WNT Signaling for Multifaceted Glioblastoma Therapy
por: McCord, Matthew, et al.
Publicado: (2017)

Circular RNAs as a Diagnostic and Therapeutic Target in Cardiovascular Diseases
por: Joaquim, Victor Hugo Antonio, et al.
Publicado: (2023)

Inflammatory therapeutic targets in coronary atherosclerosis—from molecular biology to clinical application
por: Linden, Fabian, et al.
Publicado: (2014)

Regulation of CaMKII signaling in cardiovascular disease
por: Mollova, Mariya Y., et al.
Publicado: (2015)

Molecular insights into the multifaceted functions and therapeutic targeting of high mobility group box 1 in metabolic diseases
por: Tao, Zhipeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5n2li38t4vbofh60o5pp9ckjt4